2024 annual financial data
Moleculin Biotech 2024 Operating margin
Moleculin Biotech 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -26,641,000 USD and net income was -21,763,000 USD.
Operating cash flow was -23,862,000 USD.
Get free Moleculin Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,641,000 USD
- Net income
- -21,763,000 USD
- Operating cash flow
- -23,862,000 USD